ESR1 and breast cancer: Attempts to create hormone-resistant model usually involve growing a cell line (originally from the Luminal BC cell line) that has developed resistance to a particular type of hormone therapy, such as tamoxifen (selective estrogen receptor modulator), fulvestrant (ER antagonist) or aromatase inhibitors.